Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France

Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: A French payer perspective

(2014) Julie Chevalier et al.   Archives of Cardiovascular Diseases

Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) Database

(2014) Pierre Sabouret et al.   Clinical Research in Cardiology

Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries

(2014) François-Emery Cotté et al.   CLINICAL THERAPEUTICS

Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases

(2014) Charles Heng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin

(2014) T. Lanitis et al.   JOURNAL OF MEDICAL ECONOMICS

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

(2013) François Laliberté et al.   CURRENT MEDICAL RESEARCH AND OPINION

Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke

(2013) J. P. Piccini et al.   EUROPEAN HEART JOURNAL

Incidence and Cost of Stroke and Hemorrhage in Patients Diagnosed with Atrial Fibrillation in France

(2013) François-Emery Cotté et al.   Journal of Stroke & Cerebrovascular Diseases

THE OBESITY PARADOX: THE IMPORTANCE FOR LONG-TERM OUTCOMES IN NON-ST-ELEVATION MYOCARDIAL INFARCTION – THE CRUSADE EXPERIENCE

(2013) Emily Obrien et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

(2012) T. Wilke et al.   EUROPACE

Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data

(2011) Agnès Charlemagne et al.   Archives of Cardiovascular Diseases

The cost of illness of atrial fibrillation: a systematic review of the recent literature

(2011) S. E. Wolowacz et al.   EUROPACE

Comparison of Cardiovascular Risk Factors and Survival in Patients with Ischemic or Hemorrhagic Stroke

(2011) Karin M. Henriksson et al.   International Journal of Stroke

Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries

(2009) D. Leys et al.   JOURNAL OF NEUROLOGY